Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 2/20 | 0.46 |
| ▸ | TERT | O14746 | 1/20 | 0.39 |
| ▸ | F2RL1 | P55085 | 3/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | NAMPT | P43490 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL61763 | 1.00 | TBXAS1 (0.46) | TBXAS1TERTF2RL1HTR1ATAAR1 | |
| SCHEMBL22163935 | 1.00 | TBXAS1 (0.46) | TBXAS1TERTF2RL1HTR1ATAAR1 | |
| SCHEMBL22163888 | 1.00 | TBXAS1 (0.46) | TBXAS1TERTF2RL1HTR1ATAAR1 | |
| SCHEMBL727766 | 0.95 | TBXAS1 (0.42) | TBXAS1TERTF2RL1HTR1ATAAR1 | |
| SCHEMBL23071637 | 0.84 | TBXAS1 (0.59) | TBXAS1TERTHTR1ATAAR1ALDH1A1 | |
| SCHEMBL64393 | 0.84 | TBXAS1 (0.59) | TBXAS1TERTHTR1ATAAR1ALDH1A1 | |
| SCHEMBL73945 | 0.84 | TBXAS1 (0.59) | TBXAS1TERTHTR1ATAAR1ALDH1A1 | |
| SCHEMBL3497513 | 0.84 | TBXAS1 (0.59) | TBXAS1TERTHTR1ATAAR1ALDH1A1 | |
| SCHEMBL25380441 | 0.84 | TBXAS1 (0.59) | TBXAS1TERTHTR1ATAAR1ALDH1A1 | |
| SCHEMBL2775177 | 0.84 | TBXAS1 (0.59) | TBXAS1TERTHTR1ATAAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 378 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4722287-B2 | — | — | 2011-07-13 | — | — | JP | claimed |
| EP-1056752-B1 | Catalyst activators comprising expanded anions | DOW GLOBAL TECHNOLOGIES INC (US) | 2003-06-25 | — | — | EP | claimed |
| US-6395671-B2 | ANION CONTAINING TWO LEWIS BASIC SITES WHICH ARE COORDINATED TO LEWIS ACIDS; FOR OLEFIN POLYMERIZATION | THE DOW CHEMICAL COMPANY | 2002-05-28 | — | — | US | claimed |
| US-6376406-B1 | COORDINATION POLYMERIZATION CATALYSTS FOR ALPHA-OLEFINS | THE DOW CHEMICAL COMPANY | 2002-04-23 | — | — | US | claimed |
| US-20010027161-A1 | Catalyst activators comprising expanded anions | THE DOW CHEMICAL COMPANY | 2001-10-04 | — | — | US | claimed |
| EP-1056752-A1 | CATALYST ACTIVATORS COMPRISING EXPANDED ANIONS | THE DOW CHEMICAL COMPANY (US) | 2000-12-06 | — | — | EP | claimed |
| WO-1999042467-A1 | CATALYST ACTIVATORS COMPRISING EXPANDED ANIONS | THE DOW CHEMICAL COMPANY (US) | 1999-08-26 | — | — | WO | claimed |
| EP-3519456-B1 | CAPPED MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING AND PROCESS TO PREPARE THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-07-03 | — | — | EP | disclosed |
| EP-3519455-B1 | MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING AND PROCESS TO PREPARE THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4234594-A1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | Dow Global Technologies LLC (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-2024402-B2 | HIGH TEMPERATURE SOLUTION POLYMERIZATION PROCESS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-01-25 | — | — | EP | disclosed |
| US-20220204716-A1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | DOW GLOBAL TECHNOLOGIES LLC | 2022-06-30 | — | — | US | disclosed |
| US-11359038-B2 | Capped multi- or dual-headed compositions useful for chain shuttling and process to prepare the same | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-06-14 | — | — | US | disclosed |
| WO-2001058912-A1 | DINUCLEAR GROUP 4 METAL BORON OR ALUMINUM BRIDGE CONTAINING ANSA-COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 2001-08-16 | — | — | WO | disclosed |
| EP-1119575-A1 | BRIDGED METAL COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 2001-08-01 | — | — | EP | disclosed |
| WO-2001046201-A1 | GALLIUM OR INDIUM-BRIDGED GROUP 4 METAL COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 2001-06-28 | — | — | WO | disclosed |
| EP-1056752-A1 | CATALYST ACTIVATORS COMPRISING EXPANDED ANIONS | THE DOW CHEMICAL COMPANY (US) | 2000-12-06 | — | — | EP | disclosed |
| WO-2000020462-A2 | BRIDGED METAL COMPLEXES FOR GAS PHASE POLYMERIZATIONS | BP CHEMICALS LIMITED (GB) | 2000-04-13 | — | — | WO | disclosed |
| WO-2000020426-A1 | BRIDGED METAL COMPLEXES | THE DOW CHEMICAL COMPANY (US) | 2000-04-13 | — | — | WO | disclosed |
| WO-1999042467-A1 | CATALYST ACTIVATORS COMPRISING EXPANDED ANIONS | THE DOW CHEMICAL COMPANY (US) | 1999-08-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220204716-A1 | CURABLE COMPOSITIONS COMPRISING UNSATURATED POLYOLEFINS | ACSL6, ELOVL6, ALOX5 | TBXAS1 464/4885TERT 3174/4885F2RL1 3143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.